AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $5.35M invested in AIM ImmunoTech in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$638K
2
+$382K
3
+$108K
4
Millennium Management
Millennium Management
New York
+$102K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$82.7K

Top Sellers

1
-$139K
2
-$30K
3
-$27K
4
Goldman Sachs
Goldman Sachs
New York
-$6K
5
ICAS
Investors Capital Advisory Services
Massachusetts
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.8M
2
$1.59M
3
$912K
4
$310K
5
$115K
6
$108K
7
$102K
8
$97K
9
$68K
10
$59K
11
$36K
12
$35K
13
$27K
14
$22K
15
$14K
16
$12K
17
$12K
18
$6K
19
$6K
20
$4K
21
$4K
22
$2K
23
–
24
–
25
–